Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only in the first quarter of 2024.

Nordic Bioscience Canada France Germany Spain United States of America United Kingdom Denmark China

Tel. [phone]
For product related inquires please use https://www.nordicbioscience.com/contact 

About Nordic Bioscience

Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. Nordic Bioscience is engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.

Photo - https://mma.prnewswire.com/media/2334368/ROCHE_NORDIC_PRO_C3_CHINA.jpg
Logo - https://mma.prnewswire.com/media/2334369/Nordic_Bioscience_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/nordic-bioscience-to-make-its-precision-medicine-biomarker-pro-c3-available-in-china-for-research-use-only-ruo-in-the-first-quarter-of-2024-302053591.html